Cordyceps Sunshine Biotech Holdings (RAJAF) Payables (2020 - 2025)

Cordyceps Sunshine Biotech Holdings' Payables history runs 5 years deep, the most recent figure standing at $4.0 million for Q4 2025.

• In Q4 2025, Payables rose 2.68% year-over-year to $4.0 million; the TTM figure through Dec 2025 stood at $4.0 million (up 2.68% YoY), while the FY2025 annual figure was $4.0 million, up 2.68% from the prior year.
• Payables was $4.0 million for Q4 2025 at Cordyceps Sunshine Biotech Holdings, up from $3.9 million in the prior quarter.
• In the past five years, Payables ranged from a high of $4.0 million in Q4 2025 to a low of $1.2 million in Q4 2021.
• Historically, Payables has averaged $2.6 million across 4 years, with a median of $2.6 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Payables surged 49.97% in 2024, then grew 2.68% in 2025.
• A 4-year view of Payables shows it stood at $1.2 million in 2021, then soared by 113.03% to $2.6 million in 2023, then jumped by 49.97% to $3.9 million in 2024, then climbed by 2.68% to $4.0 million in 2025.
• The last three Payables figures came in at $4.0 million (Q4 2025), $3.9 million (Q4 2024), and $2.6 million (Q4 2023), per Business Quant data.